Open AccessMetabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Author(s) -
Guangyi Huang,
Zhiqi Huang,
Yunling Peng,
Yuehai Wang,
Weitao Liu,
Yiguo Xue,
Wenbo Yang
Publication year - 2021
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s323379
Subject(s) - proteomics , dilated cardiomyopathy , ischemic cardiomyopathy , medicine , heart failure , cardiomyopathy , gene , bioinformatics , computational biology , biology , genetics , ejection fraction
Ischemic cardiomyopathy (ICM) and nonischemic dilated cardiomyopathy (DCM) are the two most common causes of heart failure. However, our understanding of the specific proteins and biological processes distinguishing DCM from ICM remains insufficient.